$MRNA
Market closedModerna, Inc. · NasdaqGS
$214.17
▲ $6.195 (2.98%)
Open
$203.97
Prev close
$207.97
Day range
$202.62 – $218.16
Volume
11.99M
Avg volume
20.92M
Market cap
$85.50B
P/E (TTM)
—
Forward P/E
-46.71
EPS (TTM)
-8.22
52wk change
+767.06%
1M performance
+8.56%$197.28 → $214.16
Latest news
Breakthrough cancer vaccine catches Wall Street's attention
TheStreet · 6h ago
Here’s Why Moderna’s CEO Isn’t Fazed by Its Cancer-Vaccine Selloff
The Wall Street Journal · 8h ago
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
24/7 Wall St. · 12h ago
South & Central America DNA Plasmid Manufacturing Market Size, Share, Trends, and Forecast, 2021 - 2031 | Gene Therapies and mRNA Vaccines Drive 15.8% CAGR to US$48.8 Million
GlobeNewswire · 13h ago
Axsome Therapeutics vs. Moderna: Consistent Revenue Growth or Sharp Volatility
Motley Fool · 14h ago
Strand Therapeutics Doses First Patients with STX-003, a Systemic Programmable mRNA Therapy Designed for Tumor-Selective Activation
Business Wire · 15h ago
What moved $MRNA before
Logged catalysts for this stock, with the price reaction measured from real closes.
| Date | Factor | What happened | Next day | 1 week | 1 month | vs S&P |
|---|---|---|---|---|---|---|
| Nov 16, 2020 | 🧪 Clinical trial results | Covid vaccine interim efficacy reported at roughly 94% | +9.58% | +9.20% | +64.69% | +8.33% |
Predictions on $MRNA
Make a call →Discussions on $MRNA
Start one →Market data from Yahoo Finance. Prices may be delayed. Not financial advice.